In conclusion, these studies identify novel biomarkers that can be used to objectively define TERTpWT-IDHWT GBM tumors and have discovered a novel role of somatic SMARCAL1 loss-of-function mutations in the ALT phenotype in human cancers. This evidence concerns the gene GPT and cancer.